Every aspect of science and research is based on data, and across the globe, labs are producing more data than the average person can even comprehend. With the increasing digitalisation of research, facilities are experiencing steady growth in dat... Read more
Since 2019, Cytiva has committed over $1.6 billion to expand its global manufacturing capacity. In this exclusive conversation with BioPharma BoardRoom, Pierre-Alain Ruffieux, Chief Operating Officer at Cytiva, shares the strategic thinking behind th... Read more
ADCs are no longer a niche modality. To date, there are over a dozen approved ADCs on the market, and more than 500 programs are in clinical development, driving the global market past $11 billion in 2023 and toward a projected compound annual growth... Read more
As the world recalibrates its life sciences infrastructure post-pandemic, Australia is stepping up as a regional powerhouse in biomanufacturing—especially in the realm of viral vectors and cell and gene therapy. At the heart of this transformat... Read more
Financing led by Novo Holdings with significant support from world-class group of existing and new investors Proceeds from financing to support development of first-in-class IgG4-targeted protein degrader program through clinical proof-of-concept ... Read more
Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights offering for small and mid-sized labs worldwide with easy-to-use, fast and flexible NGS data... Read more
In a significant move to accelerate the global fight against blood cancers and hard-totreat solid tumours, renowned end- to-end biologics CDMO Mabion have entered into a strategic development and manufacturing partnership with London based NovalGen... Read more
ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation... Read more
© 2025 Biopharma Boardroom. All Rights Reserved.
